Section
Policy
IRA, state PBM reform, Medicare, and regulatory action
PolicyEndpoints News ↗
Last week at our biopharma and healthcare summit with the Financial Times, I was asked during one of our break…
PolicySTAT News ↗
It's part of Democrats' strategy to focus on health care affordability and access in drawing contrasts with Re…
PolicyBriefing
The Justices declined to review challenges from AstraZeneca, Novo Nordisk, and others, leaving CMS authority o…
PolicySTAT News ↗
With no approved vaccine for the fast-growing Ebola outbreak in the DRC, experts weigh testing one with unknow…
PolicySTAT News ↗
A number of Americans who are in the Congo are believed to have had exposure to suspected cases in the country…
PolicyBriefing
The Commerce Department now requires drugmakers seeking reduced import tariffs to submit detailed onshoring da…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.